TradingView vs Koyfin (2026):
Charting vs fundamental research — which do you actually need?
TradingView dominates technical charting, price alerts, and ETF monitoring. Koyfin dominates fundamental data, financial statement analysis, and equity screening. They are not really direct competitors — most investors only need one, and the right pick becomes obvious once you know how you actually invest.
Some of the links on this site are affiliate links, meaning we may earn a commission at no extra cost to you if you sign up through them. This does not affect our reviews or recommendations — we only feature products we genuinely believe are useful for investors. This site provides educational content only, not personalized investment advice. Investments can lose value and past performance does not guarantee future results. You are responsible for your own financial decisions and for confirming the tax and legal rules that apply in your country.
TL;DR — the short answer
Two tools solving two different problems. Here is where each wins and loses, before we go into the detail.
- Want the best charting platform available to retail investors
- Track ETF or stock prices and need reliable alert triggers
- Trade crypto, forex, or futures alongside equities
- Want community scripts, Pine Script, and shared ideas
- Need broker-integrated execution from the chart interface
- Are a passive ETF investor who checks in monthly
- Do deep fundamental analysis on individual stocks
- Need 10+ years of financial statement history
- Use analyst consensus estimates and earnings transcripts
- Screen stocks by 500+ financial metrics
- Work with macro data, yield curves, and economic datasets
- Want an institutional-grade research workflow at retail pricing
Feature comparison at a glance
Every major dimension, in one table. Prices are indicative — always check current plan pages before subscribing.
| Feature | TradingView | Koyfin |
|---|---|---|
| Best for | Traders & ETF chart users | Fundamental stock investors |
| Technical charting | Industry-leading (400+ indicators) | Basic (no Pine Script) |
| Fundamental data depth | Shallow — basic ratios only | 10+ years of full financials |
| Stock screener filters | ~150 metrics | 500+ metrics |
| Analyst estimates & transcripts | Not available | Full consensus + earnings transcripts |
| Crypto & forex coverage | Excellent | Limited |
| UCITS ETF charting | Good | Good |
| ETF holdings / constituents | Not available | Full constituent breakdown |
| Macro data & yield curves | Limited | Extensive |
| Community & social features | Large community, shared ideas | None — solo research platform |
| Custom scripting | Pine Script (powerful) | Not available |
| Broker trading integration | Yes (select brokers) | No |
| Price alerts | Excellent — push, email, webhook | Basic |
| Portfolio tracking | Basic | Good — with performance analytics |
| Free plan | Yes (ad-supported, functional) | Yes (limited history, ad-free) |
| Starting paid price | ~€13–15/mo (Essential, billed annually) | ~$39/mo (Plus, billed annually) |
| Mobile app | Excellent | Good |
| Learning curve | Medium | High |
TradingView wins this category — it’s not close
If charting quality matters to your workflow, this is settled before you read another word. TradingView is the industry standard for browser-based charting. Koyfin has charts; TradingView is built around them.
- 17+ chart types including candlestick, Heikin-Ashi, Renko
- 400+ built-in indicators; thousands more from the community library
- Pine Script — write custom indicators and strategy backtests
- Multi-chart layouts on one screen (up to 8 on Premium)
- Bar Replay to step through historical price action
- Drawing tools, Fibonacci levels, Elliott Wave tools
- Real-time data across stocks, ETFs, crypto, forex, futures, indices
- Clean price charts with basic technical indicators
- Can overlay fundamentals onto price — e.g. chart P/E ratio against stock price over time
- Sector and macro comparison charts are genuinely strong
- No Pine Script, no community indicator library, no drawing tools
- Not designed for active technical traders — and it doesn’t pretend to be
Koyfin wins this category — by a significant margin
TradingView surfaces enough fundamental data to decorate a chart. Koyfin is built to power actual equity research. The gap between them on this dimension is large.
- 10+ years of income statements, balance sheets, and cash flow statements
- Wall Street analyst consensus estimates with historical accuracy tracking
- Full earnings call transcripts — searchable by keyword
- SEC / regulatory filing access
- Segment-level revenue breakdowns for multi-business companies
- Valuation models: DCF templates, comparable company analysis
- Dividend history, buyback data, insider ownership
- Institutional-style customisable dashboards for each position
- Core ratios available: P/E, EV/EBITDA, P/S, P/B, dividend yield
- Recent earnings surprises shown on the chart timeline
- Limited financial history — not suitable for multi-year trend analysis
- No analyst estimates, no earnings transcripts, no SEC filing viewer
- Adequate for a quick fundamental check; inadequate for actual research
Two different screeners serving two different jobs
TradingView’s screener is built for technical setups. Koyfin’s is built for fundamental filtering. Neither replaces a dedicated ETF database for UCITS research.
Filter by RSI, moving average crossovers, volume conditions, and basic fundamental ratios. Roughly 150 metrics. Set screener alerts to notify you when conditions are met. The ETF screener covers UCITS instruments but is not designed to replace a purpose-built ETF tool for European investors — for that, see the best ETF screeners for Europe.
500+ financial metrics including revenue growth rates, return on equity, free cash flow yield, debt ratios, and analyst estimate revisions. Designed for factor-based and value investing workflows. You can build a watchlist of stocks matching a specific fundamental profile and monitor it ongoing — something TradingView’s screener cannot do at this depth.
TradingView is broader; Koyfin is deeper on equities
What each platform actually covers — and where each has blind spots.
| Asset class / data type | TradingView | Koyfin |
|---|---|---|
| Global equities | Excellent — price data | Excellent — price + fundamentals |
| UCITS ETFs | Good — charting and price | Good — holdings and comparisons |
| Crypto | Excellent | Very limited |
| Forex | Excellent | Moderate |
| Futures & commodities | Strong | Moderate |
| Bonds & fixed income | Limited | Strong — yield curves, bond data |
| Macroeconomic data | Limited | Extensive — GDP, CPI, labour, rates |
| Mutual funds | Limited | Good |
TradingView is meaningfully cheaper at every tier
Both have free plans. TradingView’s first paid step is roughly a third of Koyfin’s. The pricing reflects what each platform is — TradingView is a consumer charting tool; Koyfin is priced for professional research use.
| Plan tier | TradingView | Koyfin |
|---|---|---|
| Free | Yes — ad-supported, 1 chart/layout, limited indicators & alerts | Yes — ad-free, 2-year financial history, limited screening |
| Entry paid | Essential: ~€13–15/mo (annual) — no ads, Bar Replay, 2 charts/layout | Plus: ~$39/mo (annual) — full financial history, more screening filters |
| Mid tier | Plus: ~€25/mo — 4 charts/layout, more alerts, saved layouts | Premium: ~$79/mo — mutual fund data, advanced dashboards |
| Top tier | Premium: ~€50/mo — 8 charts/layout, fastest data, maximum alerts | Advisor: ~$299/mo — client report branding, team workflows |
| Ultimate | Ultimate: highest capacity — rarely relevant for retail | — |
Start on Free and use it for at least two to three months. Most passive ETF investors who contribute monthly and check in occasionally never outgrow it. Essential (formerly Pro) is worth upgrading to if you regularly set price or indicator alerts and find the Free limit is genuinely blocking you — or if ads in a financial tool irritate you. See the full TradingView Free vs Pro breakdown before paying.
Koyfin’s Plus tier at ~$39/month is a reasonable tool cost if you actively research stocks and currently pay for multiple inferior data sources. The break-even logic: if Koyfin replaces a Bloomberg data subscription, a separate screener, and a financial data service, the bundled cost makes sense. If you are a passive investor who checks one ETF chart per month, you are massively overpaying for what you use.
TradingView is a platform; Koyfin is a workstation
The experience of using these tools day-to-day is fundamentally different — not just in features, but in what kind of investor they are designed for.
TradingView has a large social layer — users publish annotated chart ideas, custom indicators, and open-source Pine Scripts. You can browse how other investors analyse the same ETF or index and adapt those setups. The risk: many shared ideas are confirmation bias presented as analysis. Browse for perspective, never copy for execution.
The platform runs on web, desktop (Windows / Mac / Linux), and mobile, with all three tightly synced. Alerts set on desktop push to mobile instantly — the most practical feature for investors who do not want to check prices daily.
Koyfin has almost no social layer. It is designed for private, concentrated research — building a dashboard for a single company position, setting up a watchlist of 20 stocks you are tracking through earnings season, or presenting research to a client. The customisable dashboards are genuinely institutional in feel.
The learning curve is real. It takes time to understand how to build effective watchlists, set up the right dashboard layout, and interpret the data. TradingView is intuitive out of the box; Koyfin rewards investors who put in the setup time.
The honest shortlist for each platform
- Best browser-based charting available to retail investors
- Free plan is genuinely functional, not a gated demo
- Alert system is reliable and pushes to mobile
- Pine Script enables fully custom indicators and backtesting
- Covers equities, crypto, forex, futures from one interface
- Broker integration for supported accounts
- Strong mobile app — one of the best in this category
- Ads on Free plan are aggressive — paid tier removes them
- Fundamental data depth is too shallow for serious equity research
- Pine Script has a learning curve; community scripts vary wildly in quality
- Heavy chart use can become a substitute for actually having a plan
- Institutional-grade data at a retail price point
- 10+ years of financial statements — enough to track full business cycles
- Analyst estimates and earnings transcripts in one place
- 500+ screening filters for genuine factor-based stock selection
- Strong macro and economic data — useful for top-down investors
- ETF constituent breakdowns with full holdings data
- Expensive relative to TradingView — $39/mo is not casual money
- Steep learning curve before you can use it effectively
- No broker integration — research only, execution elsewhere
- Crypto and forex coverage is weak
- Community and social features essentially do not exist
Who should use which — a direct answer
Stop second-guessing it. Here is the framework based on how you actually invest.
- Your portfolio is mostly UCITS ETFs and you contribute monthly
- You want to monitor price levels and set alerts without checking daily
- You trade or actively watch crypto or forex
- You are a technical trader using indicators and chart patterns
- You want a free tool that actually works without paywalling the basics
- You want Pine Script to build and test custom strategies
- You want the social layer — browsing ideas, open-source indicators
- You run a concentrated stock portfolio and analyse companies in depth
- You need analyst estimates, earnings transcripts, or SEC filings
- You use factor-based investing and need to screen 500+ fundamental metrics
- You track macroeconomic data — rates, inflation, yield curves — as part of your process
- You are a financial advisor or professional presenting research to clients
- You currently subscribe to multiple data tools and want to consolidate
Some active investors do use both — TradingView for charting, alerts, and price monitoring; Koyfin for fundamental research and screening. That combination costs roughly €50–80/month total and is only worth it if you are genuinely using both workflows regularly. For the vast majority of European retail investors building a long-term ETF portfolio, TradingView Free covers everything you actually do. Start there.
Other tools worth considering
Neither TradingView nor Koyfin is the only option in its category. Depending on your workflow, one of these may be a better or cheaper fit.
- TIKR — strong 10+ year financials, often cheaper than Koyfin for pure fundamental research
- Stock Analysis — free fundamental data, simpler interface, good for most retail needs
- Simply Wall St — visual, beginner-friendly fundamental analysis; less raw data depth
- Stockopedia — quantitative factor scoring on top of fundamental data, strong for UK investors
- TrendSpider — more automated technical analysis, higher price point
- GoCharting — lighter, free-tier-friendly charting for simpler setups
- Your broker’s built-in charts — good enough if you only check prices occasionally and do not need alerts or multi-chart layouts
TradingView’s Free plan is fully functional for most ETF investors. Koyfin’s Free tier gives you a real taste of the fundamental research workflow. Use both for a month before paying for either — you will know quickly which one you actually reach for.
Go deeper on the tools that matter
Free vs Pro breakdown, alert system, ETF research use cases, and when upgrading is actually worth it.
Every limit that changes when you upgrade — and whether those limits are actually costing you anything.
How to configure TradingView specifically for European ETF monitoring and comparison.
Full review of Koyfin’s features, pricing, and whether it’s worth it for retail investors.
Both are fundamental research tools. Here is how they split on data depth, pricing, and which investor each is built for.
Free vs paid fundamental research. When Stock Analysis is enough and when Koyfin’s depth justifies the price.
Visual beginner-friendly analysis vs institutional-grade research. Which fits your workflow?
Quantitative factor scoring vs raw fundamental data. Two different philosophies for stock research.
The best screeners available to European investors — ranked by data quality, filter depth, and whether free is actually enough.
Purpose-built UCITS ETF screening tools — what each covers and which is worth using for your fund selection process.
Common questions
Is TradingView or Koyfin better for ETF investors?
TradingView is better for ETF investors who want to monitor price action, set alerts, and compare ETFs on a chart. Koyfin is better if you want to screen ETFs by holdings, analyse constituent data, or overlay macroeconomic variables. Most passive ETF investors doing monthly contributions will get more day-to-day value from TradingView’s Free plan. Koyfin’s ETF tools are strong but require a research workflow that most passive investors do not have.
Can you buy stocks or ETFs directly on Koyfin?
No. Koyfin is a pure research and analysis platform — there is no broker integration and no ability to place trades from within the platform. You use Koyfin to research, then execute through a separate brokerage account. TradingView, by contrast, does support broker-integrated execution for supported brokers — though the platform remains an analysis interface rather than a custodian.
Does Koyfin have a free plan?
Yes, Koyfin offers a free tier. It is ad-free but restricts financial history to roughly 2 years, limits the number of screening criteria, and caps dashboard customisation. It is functional for light research but you will hit its limits quickly if you do regular fundamental analysis. TradingView’s Free plan is more generous in its charting capability, though it is ad-supported.
Which is cheaper — TradingView or Koyfin?
TradingView is significantly cheaper. Its first paid tier (Essential) starts around €13–15/month billed annually. Koyfin’s first paid tier (Plus) starts around $39/month. Both offer a functional free tier, but TradingView’s free plan is more capable out of the box. Paying for both simultaneously costs roughly €50–80/month total and is only justified for investors with active technical and fundamental research workflows.
Is Koyfin a good Bloomberg Terminal alternative?
For retail investors, yes. Koyfin covers 10+ years of financial statement history, analyst consensus estimates, earnings transcripts, macro datasets, and 500+ screening filters — capabilities that previously required institutional software. It does not match Bloomberg’s breadth or real-time data depth, but it costs a fraction of the price and covers what most individual investors actually need. The “retail Bloomberg” framing is marketing language, but it is not far off.
Does TradingView have fundamental data?
TradingView includes basic fundamental data — P/E ratio, revenue, earnings — that you can overlay on price charts. But its financial history is shallow and it lacks analyst estimates, earnings transcripts, or institutional-grade screening by financial metrics. If fundamental analysis is a core part of your workflow, Koyfin, TIKR, or Stock Analysis are stronger tools for that job.
Do most investors need both TradingView and Koyfin?
Some active investors do use both — TradingView for charting, alerts, and price monitoring; Koyfin for fundamental research and screening. That combination costs roughly €50–80/month total and is only justified if you genuinely use both workflows regularly. For the vast majority of European retail investors building a long-term ETF portfolio, TradingView Free covers everything you actually do. Koyfin adds value when you actively research individual equities — which most passive investors do not.
QuantRoutine provides educational content only. Nothing on this page is an offer or recommendation to buy any financial product or service. Pricing and plan information for TradingView and Koyfin changes frequently — always verify current plan details and pricing on each platform’s official website before subscribing. TradingView is an affiliate partner of QuantRoutine; Koyfin is not.